Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DoseDr
AddedMar 22, 2024
UpdatedJul 3, 2026
DoseDr

DoseDr

Closed

Free app for diabetes management, connecting patients with doctors for immediate help adjusting insulin doses.

HQ
Menlo Park, CA, US
Founded
2015
Accelerator
Y Combinator logoY CombinatorW16
Overview
Compare
Fundraising
Employees

DoseDr's mission is to empower diabetes patients by providing a free mobile app that helps them manage their insulin doses more effectively. The app connects patients with doctors for immediate assistance, eliminating the need for appointments. This service aims to improve patient outcomes by offering real-time support and personalized care.

DoseDr has significantly impacted diabetes management by enhancing patient-doctor communication and providing timely medical advice. The app's user-friendly interface and accessibility have garnered positive feedback from both patients and healthcare professionals, contributing to better disease control and patient satisfaction.

DoseDr - Similar Companies

One Drop logo

One Drop

onedrop.today

DarioHealth logo

DarioHealth

DocTalk logo

DocTalk

getdoctalk.com

Databetes logo

Databetes

MediPocket logo

MediPocket

PillDrill logo

PillDrill

pilldrill.com

DrAvailable logo

DrAvailable

Hygieia logo

Hygieia

hygieia.com

DocBuddy logo

DocBuddy

docbuddy.com

GetDoctor logo

GetDoctor

getdoctor.co

Medcorder logo

Medcorder

medcorder.com

ithnain logo

ithnain

ithnain.com

DailyDoctor logo

DailyDoctor

mydailydoctor.com

Doctoroo logo

Doctoroo

doctoroo.com

Medmonk logo

Medmonk

medmonk.com

DoseDr - Quick Facts

Who are DoseDr's competitors?

Companies similar to DoseDr include One Drop, DarioHealth, DocTalk and Databetes.

When was DoseDr founded?

DoseDr was founded in 2015.

Where is DoseDr's headquarters located?

DoseDr's headquarters is located in Menlo Park, CA, US.

When was DoseDr's last funding round?

DoseDr's most recent funding round was for $120k (USD) in March 2016.

How much has DoseDr raised to-date?

As of Mar 22, 2016, DoseDr has raised a total of $120k (USD).

DoseDr - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Telemedicine
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Diabetes Management
  • Mobile App
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified